blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1959931

EP1959931 - COMPOSITIONS AND METHODS FOR DERMALLY TREATING PAIN [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  28.10.2016
Database last updated on 26.06.2024
Most recent event   Tooltip28.10.2016Application deemed to be withdrawnpublished on 30.11.2016  [2016/48]
Applicant(s)For all designated states
ZARS Pharma, Inc.
1455 West 2200 South, Suite 300
Salt Lake City, UT 84119 / US
[2008/50]
Former [2008/35]For all designated states
Zars, Inc.
1142 W. 2320 S.
Salt Lake City, UT 84119 / US
Inventor(s)01 / ZHANG, Jie
6232 S. Lorreen Drive
Salt Lake City, UT 84121 / US
02 / WARNER, Kevin, S.
6224 Uinta Hills Drive
West Jordan, UT 84088 / US
03 / SHARMA, Sanjay
11633 S. Brisbane Dr.
Sandy, UT 84094 / US
 [2008/35]
Representative(s)Walker, Ross Thomson, et al
Forresters IP LLP
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
[N/P]
Former [2014/10]Walker, Ross Thomson, et al
Forresters
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
Former [2012/16]Walker, Ross Thomson, et al
Forresters
15 Hamilton Square
Birkenhead
Merseyside CH41 6BR / GB
Former [2008/35]Wombwell, Francis, et al
Potts, Kerr & Co. 15, Hamilton Square Birkenhead
Merseyside CH41 6BR / GB
Application number, filing date06848632.314.12.2006
[2008/35]
WO2006US47926
Priority number, dateUS20050750519P14.12.2005         Original published format: US 750519 P
US20050750637P14.12.2005         Original published format: US 750637 P
US20050750683P14.12.2005         Original published format: US 750683 P
[2008/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007070679
Date:21.06.2007
Language:EN
[2007/25]
Type: A2 Application without search report 
No.:EP1959931
Date:27.08.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 21.06.2007 takes the place of the publication of the European patent application.
[2008/35]
Search report(s)International search report - published on:US08.01.2009
(Supplementary) European search report - dispatched on:EP25.07.2012
ClassificationIPC:A61K9/12, A61K31/74
[2012/34]
CPC:
A61K9/0014 (EP); A61P21/00 (EP); A61P25/00 (EP);
A61P29/00 (EP); A61K47/10 (EP); A61K47/18 (EP)
Former IPC [2009/09]A01N37/12
Former IPC [2008/35]A61K9/12
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/35]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR DERMALEN SCHMERZBEHANDLUNG[2008/35]
English:COMPOSITIONS AND METHODS FOR DERMALLY TREATING PAIN[2008/35]
French:COMPOSITIONS ET PROCEDES POUR LE TRAITEMENT DERMIQUE DE LA DOULEUR[2008/35]
Entry into regional phase24.06.2008National basic fee paid 
24.06.2008Search fee paid 
24.06.2008Designation fee(s) paid 
24.06.2008Examination fee paid 
Examination procedure25.06.2008Examination requested  [2008/35]
25.02.2013Amendment by applicant (claims and/or description)
04.06.2014Despatch of a communication from the examining division (Time limit: M04)
14.10.2014Reply to a communication from the examining division
01.07.2016Application deemed to be withdrawn, date of legal effect  [2016/48]
28.07.2016Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2016/48]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  04.06.2014
Fees paidRenewal fee
24.12.2008Renewal fee patent year 03
28.12.2009Renewal fee patent year 04
27.12.2010Renewal fee patent year 05
12.12.2011Renewal fee patent year 06
11.12.2012Renewal fee patent year 07
12.12.2013Renewal fee patent year 08
11.12.2014Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
31.12.201510   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO9729735  (UNIV MONASH [AU], et al) [Y] 1-42 * page 10, lines 10-11 * * page 14, lines 4-6 * * page 24, lines 9-30 *;
 [Y]WO0137890  (KO THOMAS SAI YING [AU]) [Y] 1-42 * page 4, lines 14-22 * * page 5, lines 21-36 * * page 6, lines 1-3, 9-36 * * pages 7-15 * * page 16, lines 1-12 *;
 [Y]US2004018241  (HOUZE DAVID [US], et al) [Y] 1-42 * page 3, paragraphs 52, 55, 58 *;
 [Y]  - KONDO S ET AL, "Enhancement of transdermal delivery by superfluous thermodynamic potential. I. Thermodynamic analysis of nifedipine transport across the lipoidal barrier", JOURNAL OF PHARMACOBIO-DYNAMICS, TOKYO, JP, (19870101), vol. 10, ISSN 0386-846X, pages 587 - 594, XP002611468 [Y] 1-42 * the whole document *

DOI:   http://dx.doi.org/10.1248/bpb1978.10.587
International search[Y]WO0137890  (KO THOMAS SAI YING [AU]);
 [Y]US6432415  (OSBORNE DAVID W [US], et al);
 [Y]  - PADILLA ET AL., "TOPICAL MEDICATIONS FOR OROFACIAL NEUROPATHIC PAIN: A REVIEW", J. AM. DENT. ASSOC., (2000), vol. 131, no. 2, pages 184 - 195, XP008131443
 [Y]  - FARBER ET AL., "Serotonergic Agents That Activate 5HT2A Receptors Prevent NMDA Antagonist Neurotoxicity", NEUROPSYCHOPHARMACOLOGY, (1998), vol. 18, no. 1, pages 57 - 62, XP002396767

DOI:   http://dx.doi.org/10.1016/S0893-133X(97)00127-9
ExaminationWO0122907
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.